TLR2 signaling promotes IL-10 production from DCs and Tregs and proliferation of Tregs, resulting in a decreased production of inflammatory cytokines and a marked attenuation of imiquimod-induced psoriasis skin inflammation (Figure 7). Here, IL10 is linked to psoriasis.